Escape to the future: Pharmaceutical industry wants to improve access to medicines

The planned measures by the member companies of the European Federation of Pharmaceutical Industries and Associations (EFPIA), which include 20 of the world’s largest pharmaceutical companies, are intended to “significantly increase” the availability of innovative medicines in EU countries. In addition, patients’ waiting time for new medicines is to be reduced by several months, according to the current EFPIA statement.

Continue reading now

Get 30 days of free access to the Decision Brief to read these and more quality news every day.

Are you already a guest at the Europe.Table? Log in now

Related

    Scholz and the EU: marching in solidarity
    Tech sanctions: large holes in the net
    E-fuels: Is von der Leyen putting pressure on Timmermans?
    Czech Minister of European Affairs Bek: ‘Gas emergency plan is not the final solution’